AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7036726
Drug: Diltiazem 240
RxNorm normalized name: diltiazem 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 240 mg per day
Trial: 6355242
Drug: Diltiazem 360
RxNorm normalized name: dilTIAZem 360 mg/24 hours oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 360 mg per day
Trial: 6355242
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose diltiazem
Trial: 30151229
Drug: High-protein diet
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-protein diet (+50 g protein per day)
Trial: 24331630
Drug: Enhanced nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced nutritional therapy (n = 25)
Trial: 14557756
Drug: FTY720 (0.125,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FTY720 (0.125, 0.25, 0.5, 1.0, 2.5, or 5.0 mg/day)
Trial: 8774628
Drug: Antioxidant regimen
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant regimen (vitamins E, C and N‐acetylcysteine) in chemotherapy group
Trial: 8774628
Drug: Placebo in
RxNorm normalized name: placebo INTRAVEN VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo in chemotherapy group
Trial: 31168845
Drug: Curcuminoids plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcuminoids plus piperine (500 mg curcuminoids and 5 mg piperine daily)
Trial: 2527729
Drug: Seven low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Seven low-dose oral contraceptive preparations (monophasic and triphasic levonorgestrel, monophasic and biphasic desogestrel, monophasic norethisterone, monophasic cyproterone acetate, triphasic gestodene)
Trial: 2527729
Drug: Seven low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Seven low-dose oral contraceptive preparations
Trial: 326635
Drug: Antibiotics effective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics effective against obligate anaerobes
Trial: 31587982
Drug: Intravenous Dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous Dexamethasone (DEX) 0.15 mg/kg
Trial: 31036337
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment consisting of a slow infusion of 20 mg/kg ferric carboxymaltose, 40,000 U subcutaneous erythropoietin alpha, 1 mg subcutaneous vitamin B12, and 5 mg oral folic acid.
Trial: 25172229
Drug: Topical petrolatum
RxNorm normalized name: petrolatum Topical Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical petrolatum gel
Trial: 25172229
Drug: Topical silver
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical silver sulfadiazine with gauze dressings
Trial: 21455591
Drug: Augmentation mammoplasty
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmentation mammoplasty with mastopexy
Trial: 19128802
Drug: Verapamil (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (240 mg oid) for 6 months
Trial: 19128802
Drug: Trandolapril (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trandolapril (4 mg oid) for 6 months
Trial: 19128802
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of verapamil and trandolapril for additional 6 months
Trial: 11167209
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg of elemental iron a day for the first two months after childbirth
Trial: 11167209
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg of elemental iron + 0.35 mg of folic acid a day for the first two months after childbirth
Trial: 7889813
Drug: Take-home methadone
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Take-home methadone doses following each therapy session (Study 1)
Trial: 7889813
Drug: Take-home methadone
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Take-home methadone doses earned following each therapy session attended (Study 2)
Trial: 7889813
Drug: Take-home methadone
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Take-home methadone doses earned following attendance to two consecutive sessions (Study 2)
Trial: 7889813
Drug: Take-home methadone
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Take-home methadone doses (both studies)
Trial: 3608630
Drug: Single preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single preoperative application of an antibiotic with a high biliary elimination rate (ceftriaxone or apalcillin)
Trial: 3608630
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group without prophylactic antibiotic application
Trial: 29112001
Drug: Risperidone ISM
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Risperidone ISM 75 mg intramuscular injections every 4 weeks
Trial: 24587337
Drug: WGED (wholegrain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WGED (wholegrain and low postprandial insulin response grain products)
Trial: 22992702
Drug: Continuous rhLH
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous rhLH infusion
Trial: 17883958
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL YZH oral liquid, 3 times daily for 14 d
Trial: 15749498
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (LMWH) plus low-dose aspirin (LDA)
Trial: 15749498
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) plus low-dose aspirin (LDA)
Trial: 7760409
Drug: Protocol resuscitation
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol resuscitation goals (CI > or = 4.5 L/min/m2, DO2I > or = 670 mL/min/m2, VO2I > or = 166 mL/min/m2)
Trial: 357455
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg sublingual pentrinitrol
Trial: 27838874
Drug: red yeast
RxNorm normalized name: red yeast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: red yeast rice + L. casei
Trial: 17280744
Drug: Tetanus toxoid
RxNorm normalized name: Tetanus Toxoid
DrugBank: Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetanus toxoid vaccine (0.5 ml)
Trial: 11467632
Drug: Lansoprazole, 30
RxNorm normalized name: Lansoprazole, 30 mg oral tablet, disintegrating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole, 30 mg administered nasogastrically in apple juice
Trial: 11467632
Drug: Pantoprazole, 40
RxNorm normalized name: Pantoprazole, 40 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole, 40 mg administered intravenously
Trial: 7912877
Drug: Midazolam 0.08
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.08 mg kg‐1 i.m. 60 min and fentanyl 1.5 micrograms kg‐1 i.v. 2 min before induction (MF group)
Trial: 2681556
Drug: High-dose metoclopramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose metoclopramide (1 mg/kg x 4) and methylprednisolone (treatment A)
Trial: 2681556
Drug: Metoclopramide (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide (3 mg/kg x 2) combined with dexamethasone and diphenhydramine (treatment B)
Trial: 30409925
Drug: High SPF
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High SPF sunscreen (SPF 50+, PA++++) applied once daily after bath or every 4 hours for outdoor exposure >4 hours for 3 months.
Trial: 22015190
Drug: Shuxuetong injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shuxuetong injection and Tuina
Trial: 15316798
Drug: TPM 100
RxNorm normalized name: TPM
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: TPM 100 mg/d
Trial: 15316798
Drug: PROP 160
RxNorm normalized name: PROPYLENE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PROP 160 mg/d (active control)
Trial: 15316798
Drug: TPM 200
RxNorm normalized name: TPM
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: TPM 200 mg/d
Trial: 9431627
Drug: Full intervention
RxNorm normalized name: Full Marks
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full intervention (combination of clinical and occupational intervention)
Trial: 7993832
Drug: i.m. dexamethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.m. dexamethasone and oral metoclopramide for delayed emesis
Trial: 31784906
Drug: Electrical muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrical muscle stimulation in combination with heat (EMS/H)
Trial: 31347643
Drug: Fresh turmeric
RxNorm normalized name: Turmeric
DrugBank: Turmeric (DB14276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh turmeric meal (400 mg curcumin)
Trial: 31347643
Drug: Turmeric powder
RxNorm normalized name: Turmeric
DrugBank: Turmeric (DB14276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Turmeric powder meal (400 mg curcumin)
Trial: 31347643
Drug: Curcumin powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin powder meal (400 mg curcumin)
Trial: 23403817
Drug: Ridaforolimus 12.5mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ridaforolimus 12.5mg intravenously once daily for 5 consecutive days every 2 weeks in a 4-week cycle
Trial: 21138476
Drug: Melatonin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (5 mg/day, 2 hr before bedtime) for 2 months
Trial: 17313006
Drug: Routine medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine medicine (prednisone, dibazol, vitamin B complex, and Qianzheng Powder), once each day for 10 days (2 courses total).
Trial: 11471645
Drug: 15% alkaline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15% alkaline EDTA solution
Trial: 11471645
Drug: 15% acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15% acid EDTA solution
Trial: 11471645
Drug: 25% alkaline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25% alkaline EDTA solution
Trial: 8095779
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg guanabenz
Trial: 8095779
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg guanabenz
Trial: 30113724
Drug: BI 655064
RxNorm normalized name: BI 2536
DrugBank: BI 2536 (DB16107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BI 655064 (240 mg)
Trial: 31996209
Drug: Group antenatal
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group antenatal care (G-ANC) in Nigeria
Trial: 31996209
Drug: Group antenatal
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group antenatal care (G-ANC) in Kenya
Trial: 29538635
Drug: Acetaminophen (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (1 g 6-hourly for 72 hours)
Trial: 29538635
Drug: No acetaminophen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No acetaminophen (control group)
Trial: 26977740
Drug: Low-Level Laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Level Laser Therapy (LLLT) applied intraorally with GaAlAs diode laser (wavelength, 810 nm; continuous mode, output power 0.3 W; 180 sec, 4 J/cm(2))
Trial: 11014720
Drug: Fluconazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (400 mg intravenously once daily)
Trial: 1595913
Drug: 0.5% lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.5% lidocaine and bretylium 1.5 mg/kg
Trial: 1595913
Drug: bretylium administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bretylium administration
Trial: 1595913
Drug: control treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: control treatments
Trial: 6151958
Drug: Alprazolam (2.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (2.7 mg mean final dose)
Trial: 6151958
Drug: Doxepin (137.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxepin (137.5 mg mean final dose)
Trial: 27001189
Drug: Waon therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Waon therapy (once daily for 10 days, far infrared-ray dry sauna at 60℃ for 15 min, followed by 30 min bed rest covered with a blanket)
Trial: 27001189
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard medical therapy)
Trial: 25064777
Drug: Mirror therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirror therapy (MT) combined with conventional occupational therapy, physical therapy, and speech therapy for 5 d/wk, 6 h/d, over 3 weeks
Trial: 25064777
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy without MT
Trial: 22194183
Drug: Citalopram 20
RxNorm normalized name: citalopram 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram 20 mg daily (SSRI)
Trial: 22194183
Drug: Reboxetine 4
RxNorm normalized name: reboxetine 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reboxetine 4 mg twice daily (NARI)
Trial: 6244198
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g of 0.1% hydrocortisone 17‐butyrate ointment weekly for 4 weeks
Trial: 6244198
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g of 1% hydrocortisone ointment weekly for 4 weeks
Trial: 6244198
Drug: 60 g
RxNorm normalized name: aspirin 60 Grains
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 g of hydrocortisone 17‐butyrate weekly for 4 weeks
Trial: 6244198
Drug: 60 g
RxNorm normalized name: aspirin 60 Grains
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 g of hydrocortisone weekly for 4 weeks
Trial: 31121035
Drug: ChemoRT‐GS (combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ChemoRT‐GS (combination therapy gene signature)
Trial: 28335622
Drug: Antidepressant Medication
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant Medication
Trial: 25500320
Drug: Group Rational
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group Rational Emotive Behavior Therapy (REBT)/CBT
Trial: 25500320
Drug: Group REBT/CBT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group REBT/CBT plus pharmacotherapy
Trial: 21378174
Drug: Diazoxide (6.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazoxide (6.0 mg/kg)
Trial: 10578225
Drug: Perindopril (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (4 mg/daily) + Hydrochlorothiazide (25 mg/daily)
Trial: 10578225
Drug: Perindopril (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (4 mg/daily) + Indapamide (2.5 mg/daily)
Trial: 10578225
Drug: Perindopril (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (4 mg/daily)
Trial: 10578225
Drug: Hydrochlorothiazide (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (25 mg/daily)
Trial: 10578225
Drug: Indapamide (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indapamide (2.5 mg/daily)
Trial: 10578225
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of P + HCT
Trial: 10578225
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of P + IND
Trial: 7788038
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg sustained-release isosorbide-5-nitrate
Trial: 2195346
Drug: Prednisone for
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone for 6 weeks followed by 5 million units of recombinant interferon alfa‐2b daily for 16 weeks
Trial: 849691
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with BCG and chemotherapy
Trial: 28391289
Drug: Web-delivered sleep
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-delivered sleep intervention (sleep-hygiene education, stimulus control, and cognitive behavioral therapy)
Trial: 21454798
Drug: Irbesartan (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan (150 and 300 mg once daily)
Trial: 17988832
Drug: GCBT+EX (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GCBT+EX (Group Cognitive Behavioral Therapy + Exercise)
Trial: 17988832
Drug: GCBT+ED (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GCBT+ED (Group Cognitive Behavioral Therapy + Education)
Trial: 8836985
Drug: Aspirin (81
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (81 mg/day) for 8 weeks
Trial: 794661
Drug: Aminophylline (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline (250 mg)
Trial: 30770432
Drug: Preferred algorithm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preferred algorithm requiring ≥3 MS-related claims from any combination of inpatient, outpatient, or DMT claims within a 1-year time period.
Trial: 22373589
Drug: Group S
RxNorm normalized name: Blood group substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group S + S: normal saline 0.15 ml/kg + normal saline 0.06 ml/kg
Trial: 22373589
Drug: Group S
RxNorm normalized name: Blood group substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group S + M: normal saline 0.15 ml/kg + midazolam 0.06 mg/kg
Trial: 22373589
Drug: Group D
RxNorm normalized name: Prostaglandin group D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group D + S: dexmedetomidine 0.6 μg/kg + normal saline 0.06 ml/kg
Trial: 22373589
Drug: Group D
RxNorm normalized name: Prostaglandin group D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group D + M: dexmedetomidine 0.6 μg/kg + midazolam 0.06 mg/kg
Trial: 20833658
Drug: Clonidine-diuretics association
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine-diuretics association
Trial: 18821668
Drug: Calcium (1,000
RxNorm normalized name: calcium carbonate 390 mg calcium (1,000 mg) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (1,000 mg/day)
Trial: 18821668
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 plus Calcium (1,000 mg/day)
Trial: 15774435
Drug: Bobath based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bobath based treatment (BB)
Trial: 15774435
Drug: Movement science
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Movement science based treatment (MSB)
Trial: 12444814
Drug: Venlafaxine (225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine (225 to 350 mg/day)
Trial: 12444814
Drug: Clomipramine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine (150 to 225 mg/day)
Trial: 10343140
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron saccharate for 8 weeks
Trial: 10343140
Drug: Erythropoietin in
RxNorm normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin in patients without response after iron treatment
Trial: 1935353
Drug: Levo-praziquantel (L-PZQ)
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levo-praziquantel (L-PZQ) at 20 mg/kg
Trial: 1935353
Drug: Praziquantel (PZQ)
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Praziquantel (PZQ) at 40 mg/kg
Trial: 6460467
Drug: Tetrabenazine (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetrabenazine (maximum dosage of 200 mg per day for three or more weeks)
Trial: 30488957
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of AT and RESP
Trial: 23373268
Drug: High-dose albumin
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose albumin group
Trial: 23373268
Drug: High-dose diuretic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose diuretic group
Trial: 20429825
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 5% lidocaine medicated plaster and pregabalin
Trial: 12045777
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine 15 mg daily